Literature DB >> 23504051

Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study.

Marco Canevelli1, Nawal Adali, Christelle Cantet, Sandrine Andrieu, Giuseppe Bruno, Matteo Cesari, Bruno Vellas.   

Abstract

Behavioral and psychological symptoms of dementia (BPSD) represent common manifestations among patients affected by Alzheimer's disease (AD). Some reports have recently classified BPSD into specific clusters/subsyndromes exploring the internal structure of the Neuropsychiatric Inventory (NPI). We evaluated whether specific behavioral subsyndromes are associated with worsening cognitive function. Mild to moderate AD patients were recruited from the cohort of the Impact of Cholinergic Treatment USe (ICTUS) study. Neuropsychiatric symptoms were classified in three subsyndromes, identified at baseline, grouping different combinations of NPI items: (1) "psychotic" ("delusions" and/or "hallucinations"); (2) "affective" ("agitation" and/or "depression" and/or "anxiety" and/or "irritability"); and (3) "behavioral" ("euphoria" and/or "apathy" and/or "disinhibition" and/or "aberrant motor behavior"). Mixed model analyses were performed to measure six-monthly changes in the ADAS-Cog score over a follow-up of 2 years, according to these subsyndromes. All analyses were stratified according to AD severity as defined by the Clinical Dementia Rating (CDR). A total of 1,375 AD subjects were recruited. No NPI cluster was found to significantly (p < 0.05) affect the rate of cognitive decline across the 3 CDR classes. Our results suggest that the cognitive course of AD is not substantially influenced by the presence of specific neuropsychiatric phenotypes. Further studies are needed to extend the present findings and identify possible biological and clinical bases for behavioral subsyndromes.

Entities:  

Mesh:

Year:  2013        PMID: 23504051     DOI: 10.1007/s00415-013-6893-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  32 in total

1.  The course of neuropsychiatric symptoms in dementia. Part I: findings from the two-year longitudinal Maasbed study.

Authors:  Pauline Aalten; Marjolein E de Vugt; Niek Jaspers; Jaspers Jolles; Frans R J Verhey
Journal:  Int J Geriatr Psychiatry       Date:  2005-06       Impact factor: 3.485

2.  Characterizing neuropsychiatric symptoms in subjects referred to dementia clinics.

Authors:  K R Peters; K Rockwood; S E Black; R Bouchard; S Gauthier; D Hogan; A Kertesz; I Loy-English; B L Beattie; A D Sadovnick; H H Feldman
Journal:  Neurology       Date:  2006-02-28       Impact factor: 9.910

Review 3.  The Neuropsychiatric Inventory: assessing psychopathology in dementia patients.

Authors:  J L Cummings
Journal:  Neurology       Date:  1997-05       Impact factor: 9.910

4.  Predictive factors of hospitalizations in Alzheimer's disease: a two-year prospective study in 686 patients of the REAL.FR study.

Authors:  T Voisin; S Andrieu; C Cantet; B Vellas
Journal:  J Nutr Health Aging       Date:  2010-04       Impact factor: 4.075

5.  Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium.

Authors:  Philippe H Robert; Frans R J Verhey; E Jane Byrne; Catherine Hurt; Peter Paul De Deyn; Flavio Nobili; Roberta Riello; Guido Rodriguez; Giovanni B Frisoni; Magda Tsolaki; Nora Kyriazopoulou; Roger Bullock; Alistair Burns; Bruno Vellas
Journal:  Eur Psychiatry       Date:  2005-01-27       Impact factor: 5.361

Review 6.  Recommended measures for the assessment of behavioral disturbances associated with dementia.

Authors:  Yun-Hee Jeon; Jan Sansoni; Lee-Fay Low; Lynn Chenoweth; Siggi Zapart; Emily Sansoni; Nicholas Marosszeky
Journal:  Am J Geriatr Psychiatry       Date:  2011-05       Impact factor: 4.105

7.  Disease progression meta-analysis model in Alzheimer's disease.

Authors:  Kaori Ito; Sima Ahadieh; Brian Corrigan; Jonathan French; Terence Fullerton; Thomas Tensfeldt
Journal:  Alzheimers Dement       Date:  2009-07-09       Impact factor: 21.566

8.  Trajectories of cognitive decline in Alzheimer's disease.

Authors:  Patricia A Wilkosz; Howard J Seltman; Bernie Devlin; Elise A Weamer; Oscar L Lopez; Steven T DeKosky; Robert A Sweet
Journal:  Int Psychogeriatr       Date:  2009-09-28       Impact factor: 3.878

Review 9.  Psychosis of Alzheimer's disease: clinical characteristics and history.

Authors:  Lon S Schneider; Karen S Dagerman
Journal:  J Psychiatr Res       Date:  2004-01       Impact factor: 4.791

10.  Comparison of behavioral and psychological symptoms in early-onset and late-onset Alzheimer's disease.

Authors:  Yasutaka Toyota; Manabu Ikeda; Shunichiro Shinagawa; Teruhisa Matsumoto; Naomi Matsumoto; Kazuhiko Hokoishi; Ryuji Fukuhara; Tomohisa Ishikawa; Takaaki Mori; Hiroyoshi Adachi; Kenjiro Komori; Hirotaka Tanabe
Journal:  Int J Geriatr Psychiatry       Date:  2007-09       Impact factor: 3.485

View more
  10 in total

1.  Latent classes of course in Alzheimer's disease and predictors: the Cache County Dementia Progression Study.

Authors:  Jeannie-Marie S Leoutsakos; Sarah N Forrester; Christopher D Corcoran; Maria C Norton; Peter V Rabins; Martin I Steinberg; Joann T Tschanz; Constantine G Lyketsos
Journal:  Int J Geriatr Psychiatry       Date:  2014-11-03       Impact factor: 3.485

Review 2.  Neurological update: dementia.

Authors:  A J Larner
Journal:  J Neurol       Date:  2014-02-06       Impact factor: 4.849

3.  Neuropsychiatric symptom profiles of community-dwelling persons living with dementia: Factor structures revisited.

Authors:  Natalie G Regier; Nancy A Hodgson; Laura N Gitlin
Journal:  Int J Geriatr Psychiatry       Date:  2020-05-26       Impact factor: 3.485

Review 4.  Best practice in the management of behavioural and psychological symptoms of dementia.

Authors:  Olivier Pierre Tible; Florian Riese; Egemen Savaskan; Armin von Gunten
Journal:  Ther Adv Neurol Disord       Date:  2017-06-19       Impact factor: 6.570

5.  Effectiveness and Safety of Aromatherapy in Managing Behavioral and Psychological Symptoms of Dementia: A Mixed-Methods Systematic Review.

Authors:  Becky Siu Yin Li; Carmen Wing Han Chan; Minjie Li; Irene Kit Yee Wong; Yvonne Hoi Un Yu
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2021-12-02

6.  Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations.

Authors:  Willem S Eikelboom; Esther van den Berg; Ellen H Singleton; Sara J Baart; Michiel Coesmans; Annebet E Leeuwis; Charlotte E Teunissen; Bart N M van Berckel; Yolande A L Pijnenburg; Philip Scheltens; Wiesje M van der Flier; Rik Ossenkoppele; Janne M Papma
Journal:  Neurology       Date:  2021-08-19       Impact factor: 9.910

7.  Clinical Perception and Treatment Options for Behavioral and Psychological Symptoms of Dementia (BPSD) in Italy.

Authors:  Fabrizia D'Antonio; Lucio Tremolizzo; Marta Zuffi; Simone Pomati; Elisabetta Farina
Journal:  Front Psychiatry       Date:  2022-04-01       Impact factor: 5.435

8.  Impact of behavioral and psychological symptoms of Alzheimer's disease on caregiver outcomes.

Authors:  Kanokporn Pinyopornpanish; Atiwat Soontornpun; Tinakon Wongpakaran; Nahathai Wongpakaran; Surat Tanprawate; Kanokwan Pinyopornpanish; Angkana Nadsasarn; Manee Pinyopornpanish
Journal:  Sci Rep       Date:  2022-08-19       Impact factor: 4.996

Review 9.  Comprehensive Management of Daily Living Activities, behavioral and Psychological Symptoms, and Cognitive Function in Patients with Alzheimer's Disease: A Chinese Consensus on the Comprehensive Management of Alzheimer's Disease.

Authors:  Jianjun Jia; Jun Xu; Jun Liu; Yongjun Wang; Yanjiang Wang; Yunpeng Cao; Qihao Guo; Qiuming Qu; Cuibai Wei; Wenshi Wei; Junjian Zhang; Enyan Yu
Journal:  Neurosci Bull       Date:  2021-05-29       Impact factor: 5.203

Review 10.  Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics.

Authors:  Valeria Calsolaro; Grazia Daniela Femminella; Sara Rogani; Salvatore Esposito; Riccardo Franchi; Chukwuma Okoye; Giuseppe Rengo; Fabio Monzani
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.